Tilia Fiduciary Partners’s Thermo Fisher Scientific TMO Stock Holding History

Tilia Fiduciary Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.51M	Buy	5,112 +250	+5%	+$136K	1.38%	25
2025 Q4	$2.82M	Buy	4,862 +177	+4%	+$100K	1.56%	15
2025 Q3	$2.27M	Buy	4,685 +151	+3%	+$70.3K	1.31%	32
2025 Q2	$1.84M	Buy	4,534 +415	+10%	+$174K	1.12%	39
2025 Q1	$2.05M	Buy	+4,119	New	+$2.23M	1.37%	29
2023 Q3	–	Sell	-130	Closed	-$67.9K	–	454
2023 Q2	$67.9K	Sell	130 -26	-17%	-$14K	0.06%	174
2023 Q1	$90K	Hold	156	–	–	0.09%	149
2022 Q4	$86K	Hold	156	–	–	0.08%	154
2022 Q3	$78K	Buy	156 +10	+7%	+$5.6K	0.08%	155
2022 Q2	$78K	Sell	146 -23	-14%	-$12.7K	0.07%	162
2022 Q1	$100K	Buy	169 +85	+101%	+$48.8K	0.08%	148
2021 Q4	$56K	Buy	+84	New	+$52.4K	0.05%	214

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tilia Fiduciary Partners's TMO Position: Q1 2026 in Review

Tilia Fiduciary Partners increased its Thermo Fisher Scientific (TMO) stake by 5.1% in Q1 2026, buying an estimated $136K and bringing the position to 5,112 shares worth $2.51M. The position accounts for 1.38% of the portfolio, ranked #25.

Tilia Fiduciary Partners first reported a position in TMO in Q4 2021 and has held it in 12 quarters since. The position peaked at $2.82M in Q4 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Tilia Fiduciary Partners held 5,112 shares of Thermo Fisher Scientific worth $2.51M as of Q1 2026.
Tilia Fiduciary Partners bought 250 Thermo Fisher Scientific shares in Q1 2026, an estimated $136K.
Thermo Fisher Scientific made up 1.38% of Tilia Fiduciary Partners's portfolio in Q1 2026, its #25 holding.
Tilia Fiduciary Partners first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 12 quarters since.
Tilia Fiduciary Partners's Thermo Fisher Scientific position peaked at $2.82M in Q4 2025.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Tilia Fiduciary Partners's 13F filing for Q1 2026, filed 9 Apr 2026.